Pacer Advisors, Inc. Kodiak Sciences Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$77.2 - $126.54 $47,323 - $77,569	-613 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$110.45 - $164.47 $47,051 - $70,064	-426 Reduced 41.0%	613 $70,000
Q4 2020 Jan 20, 2021	SELL	$60.78 - $154.03 $15,681 - $39,739	-258 Reduced 19.89%	1,039 $153,000
Q3 2020 Oct 19, 2020	BUY	$45.05 - $59.27 $58,429 - $76,873	1,297 New	1,297 $77,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.